In the New York Times, John Tierney writes that having a corporate connection does not necessarily bias a researcher’s work and adds that “the growing obsession with following the money too often leads to nothing but cheap ad hominem attacks.” Tierney says there are two reasons why journalists and ethics boards first look at funding when evaluating someone’s work: “laziness” and “snobbery.” He adds:

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.